Clinical trial

A Study of HS-20094 in T2DM Participants

NCT06118008

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-05-31

PhasePHASE2

Study timeline

Study start (actual)2023-05-31Date precision: day

Registry last updated2025-08-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

HS-20094 5mgDRUG

HS-20094 10mgDRUG

HS-20094 15mgDRUG

HS-20094 20mgDRUG

Sponsors & collaborators

Jiangsu Hansoh Pharmaceutical Co., Ltd.lead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06118008 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.